265 related articles for article (PubMed ID: 34797638)
21. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.
Song M; Liu T; Shi C; Zhang X; Chen X
ACS Nano; 2016 Jan; 10(1):633-647. PubMed ID: 26650065
[TBL] [Abstract][Full Text] [Related]
22. Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation.
Feng L; Xie R; Wang C; Gai S; He F; Yang D; Yang P; Lin J
ACS Nano; 2018 Nov; 12(11):11000-11012. PubMed ID: 30339353
[TBL] [Abstract][Full Text] [Related]
23. Nanoscale dual-enzyme cascade metal-organic frameworks through biomimetic mineralization as ROS generators for synergistic cancer therapy.
Jin S; Weng L; Li Z; Yang Z; Zhu L; Shi J; Tang W; Ma W; Zong H; Jiang W
J Mater Chem B; 2020 Jun; 8(21):4620-4626. PubMed ID: 32373876
[TBL] [Abstract][Full Text] [Related]
24. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
[TBL] [Abstract][Full Text] [Related]
25. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer.
Wang Y; Jiang L; Zhang Y; Lu Y; Li J; Wang H; Yao D; Wang D
ACS Appl Mater Interfaces; 2020 Jul; 12(30):33564-33574. PubMed ID: 32633941
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
Gründker C; Wokoun U; Hellriegel M; Emons G
J Obstet Gynaecol Res; 2019 Jul; 45(7):1334-1342. PubMed ID: 31016845
[TBL] [Abstract][Full Text] [Related]
27. Triple-Layered Metal-Organic Framework Hybrid for Tandem Response-Driven Enhanced Chemotherapy.
Wang F; Huang J; Xin H; Lei J
Chem Asian J; 2021 Aug; 16(15):2068-2074. PubMed ID: 34114330
[TBL] [Abstract][Full Text] [Related]
28. Zeolitic Imidazolate Framework Platform for Combinational Starvation Therapy and Oxygen Self-Sufficient Photodynamic Therapy against a Hypoxia Tumor.
Ouyang Y; Wang P; Huang B; Yang G; Tian J; Zhang W
ACS Appl Bio Mater; 2021 May; 4(5):4413-4421. PubMed ID: 35006853
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of porphyrin-incorporating covalent organic frameworks for sonodynamic therapy.
Liu S; Zhou Y; Hu C; Cai L; Liu Z; Pang M
Chem Commun (Camb); 2021 Aug; 57(66):8178-8181. PubMed ID: 34318809
[TBL] [Abstract][Full Text] [Related]
30. Post-synthesis strategy to integrate porphyrinic metal-organic frameworks with CuS NPs for synergistic enhanced photo-therapy.
Hu X; Lu Y; Zhou L; Chen L; Yao T; Liang S; Han J; Dong C; Shi S
J Mater Chem B; 2020 Feb; 8(5):935-944. PubMed ID: 31912837
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application.
Hao Y; Wang L; Zhang B; Zhao H; Niu M; Hu Y; Zheng C; Zhang H; Chang J; Zhang Z; Zhang Y
Nanotechnology; 2016 Jan; 27(2):025101. PubMed ID: 26629735
[TBL] [Abstract][Full Text] [Related]
32. Biomimetic Dual-Target Theranostic Nanovaccine Enables Magnetic Resonance Imaging and Chemo/Chemodynamic/Immune Therapy of Glioma.
Huang T; Guo Y; Wang Z; Ma J; Shi X; Shen M; Peng S
ACS Appl Mater Interfaces; 2024 May; 16(21):27187-27201. PubMed ID: 38747985
[TBL] [Abstract][Full Text] [Related]
33. Self-Assembled Minimalist Multifunctional Theranostic Nanoplatform for Magnetic Resonance Imaging-Guided Tumor Photodynamic Therapy.
Zhang H; Liu K; Li S; Xin X; Yuan S; Ma G; Yan X
ACS Nano; 2018 Aug; 12(8):8266-8276. PubMed ID: 30091901
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer.
Das R; Pulugu P; Singh AA; Chatterjee DR; Baviskar S; Vyas H; Behera SK; Srivastava A; Kumar H; Shard A
J Med Chem; 2024 Mar; 67(5):3339-3357. PubMed ID: 38408027
[TBL] [Abstract][Full Text] [Related]
36. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
37. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
Lee JS; Oh Y; Lee JS; Park JH; Shin JK; Han JH; Kim HS; Yoon S
In Vivo; 2022; 36(5):2105-2115. PubMed ID: 36099094
[TBL] [Abstract][Full Text] [Related]
38. pH-Sensitive nanotheranostics for dual-modality imaging guided nanoenzyme catalysis therapy and phototherapy.
Wang S; Mao J; Liu H; Huang S; Cai J; Gui W; Wu J; Xu J; Shen J; Wang Z
J Mater Chem B; 2020 Jun; 8(22):4859-4869. PubMed ID: 32100793
[TBL] [Abstract][Full Text] [Related]
39. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer.
Pindiprolu SKSS; Krishnamurthy PT; Dev C; Chintamaneni PK
Chem Phys Lipids; 2021 Mar; 235():105033. PubMed ID: 33385372
[TBL] [Abstract][Full Text] [Related]
40. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
